|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 672.93 USD | +3.56% |
|
+7.89% | -12.84% |
| Market Cap | 66.11B 57.85B 53.32B 49.42B 93.81B 6,274B 95.33B 639B 249B 3,097B 248B 243B 10,703B | P/E 2026 * |
16.8x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 58.24B 50.97B 46.97B 43.54B 82.65B 5,528B 83.98B 563B 219B 2,728B 219B 214B 9,429B | EV / Sales 2026 * |
3.66x | EV / Sales 2027 * | 3.16x |
| Free-Float |
72.33% | Yield 2026 * |
0.6% | Yield 2027 * | 0.68% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +3.54% | ||
| 1 week | +7.89% | ||
| Current month | +7.89% | ||
| 1 month | +10.04% | ||
| 3 months | -11.51% | ||
| 6 months | -17.18% | ||
| Current year | -12.84% |
| 1 week | 623.89 |  | 675.6 |
| 1 month | 594.9 | | 675.6 |
| Current year | 591.52 | | 821.11 |
| 1 year | 537.45 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% | ||
| 03-01 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.56% | +7.89% | +25.02% | -2.85% | 66.11B | |
| -0.24% | -3.13% | +49.38% | +223.97% | 55.3B | |
| +1.21% | +42.20% | +42.20% | +42.20% | 42.44B | |
| -0.21% | +7.44% | -48.93% | -54.50% | 41.28B | |
| -3.92% | +13.21% | +165.17% | -33.30% | 32.46B | |
| -0.58% | -4.32% | +58.86% | -24.85% | 30.78B | |
| +1.89% | +3.91% | +75.11% | +89.78% | 23.1B | |
| -3.65% | +8.93% | +1.16% | +184.50% | 20.06B | |
| -0.04% | +3.85% | +67.76% | +135.89% | 17.19B | |
| +0.94% | +5.71% | +81.00% | +366.16% | 15.23B | |
| Average | -0.13% | +5.60% | +51.67% | +92.70% | 34.39B | |
| Weighted average by Cap. | +0.28% | +4.33% | +45.02% | +68.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.9B 13.91B 12.82B 11.88B 22.56B 1,509B 22.92B 154B 59.78B 745B 59.68B 58.39B 2,574B | 17.58B 15.38B 14.18B 13.14B 24.94B 1,668B 25.35B 170B 66.11B 823B 66B 64.57B 2,846B |
| Net income | 4.09B 3.58B 3.3B 3.06B 5.8B 388B 5.9B 39.54B 15.38B 191B 15.35B 15.02B 662B | 5.13B 4.49B 4.14B 3.84B 7.28B 487B 7.4B 49.64B 19.31B 240B 19.27B 18.85B 831B |
| Net Debt | -7.87B -6.88B -6.34B -5.88B -11.16B -747B -11.34B -76.08B -29.59B -369B -29.54B -28.9B -1,274B | -10.52B -9.21B -8.49B -7.87B -14.93B -999B -15.17B -102B -39.57B -493B -39.5B -38.65B -1,704B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | US$672.81 | +3.54% | 476,622 |
| 06/07/26 | US$649.81 | -0.68% | 714,338 |
| 02/07/26 | US$654.27 | +4.73% | 1,071,604 |
| 01/07/26 | US$624.72 | +0.19% | 1,170,657 |
| 30/06/26 | US$623.54 | -1.31% | 820,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
